Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-135 with Ribavirin in Chronic Hepatitis C
NCT01790100Phase 2Completed
- Sponsor
- Alios BioPharma
- Start
- Feb 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VX-135 in hepatitis C (HCV), sponsored by Alios BioPharma. Started Feb 2013; status: completed.
02
Drugs
VX-135
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01790100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790100.